Is macrocytic erythrocyte a new prognostic parameter in critical COVID-19 disease?
Yazarlar (5)
Doç. Dr. Veysel Garani SOYLU Kastamonu Üniversitesi, Türkiye
Doç. Dr. Sedat GÜLTEN Kastamonu Üniversitesi, Türkiye
Doç. Dr. Öztürk TAŞKIN Kastamonu Üniversitesi, Türkiye
Doç. Dr. Ufuk DEMİR Kastamonu Üniversitesi, Türkiye
Dr. Öğr. Üyesi Funda Çatan İnan Kastamonu Üniversitesi, Türkiye
Makale Türü Açık Erişim Özgün Makale (Diğer hakemli uluslarası dergilerde yayınlanan tam makale)
Dergi Adı Journal of Health Sciences and Medicine
Dergi ISSN 2636-8579
Dergi Tarandığı Indeksler TR DİZİN
Makale Dili İngilizce Basım Tarihi 08-2021
Cilt / Sayı / Sayfa 4 / 6 / 828–834 DOI 10.32322/jhsm.971934
Makale Linki https://dergipark.org.tr/en/pub/jhsm/issue/64996/971934
UAK Araştırma Alanları
Tıbbi Biyokimya
Özet
Introduction In critical COVID- 19 patients, we aimed to examine the relationship mortality between the parameters and the macrocytic/microcytic erythrocyte population that are routinely evaluated in each patient admitted to the intensive care unit. Material and Method It is a retrospective cross-sectional study and was conducted in Kastamonu University, Faculty of Medicine, a tertiary hospital intensive care units located in the North of Turkey .198 nonanemic critical COVID-19 patients treated between November 2020 and February 2021 were evaluated. The patients were divided into two groups as survival and non survival. Apache II score, saps II score and routine blood examinations of the patients were evaluated. Results Among the groups; APACHE II score (p<0.001), SAPS II score (p<0.001), CRP (p<0.001), ferritin (p<0.001), d-dimer (p<0.001), platelet distribution width (p<0.009), mean platelet volume (p=0.005) and large platelet ratio (p=0.02) values ​​were higher, platelet counts (p=0.02) were lower, and these parameters were statistically significant between the two groups. There was no difference in erythrocyte distribution volume and microcytic erythrocyte percentage between the groups, but according to the cox regression analysis, each unit increase in macrocytic erythrocyte percentage was associated with a 1.203-fold increase in mortality. Conclusion Routine procedures performed in every patient admitted to the intensive care unit can provide information about mortality. Macrocytic erythrocyte percentage, which is not generally considered in non-anemic patients, may be a new marker for mortality.
Anahtar Kelimeler
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Google Scholar 1
Is macrocytic erythrocyte a new prognostic parameter in critical COVID-19 disease?

Paylaş